Resources|Podcasts|March 28, 2025
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
Author(s)PPD, Thermo Fisher Scientific
As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Related Content
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Pharma Fundamentals: Hold Times in Biopharmaceuticals
4
Biomanufacturing's Next Decade Will Be Won by Adaptability, Not Capacity
5